Tokcan, Mert
Bettink, Stephanie
Gemeinhardt, Ole
Kulenthiran, Saarraaken
Böhm, Michael
Mahfoud, Felix
Scheller, Bruno
Funding for this research was provided by:
Universität des Saarlandes
Article History
Received: 7 December 2025
Accepted: 20 May 2026
First Online: 4 June 2026
Declarations
:
: MT is supported by the Hans und Ria Messer Stiftung (HMS 20243118). SB and SK report no relationships relevant to the contents of this paper to disclose. OG is coinventor of a patent application, applicants Charité-Universitätsmedizin Berlin and InnoRa GmbH, Berlin, Germany. MB is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219, project number 322900939) and reports personal fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards, Medtronic, Novartis, ReCor, Servier and Vifor. FM has been supported by Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939), and Deutsche Herzstiftung. Saarland University has received scientific support from Ablative Solutions, Medtronic and ReCor Medical. Until May 2024, FM has received speaker honoraria/consulting fees from Ablative Solutions, Astra-Zeneca, Inari, Medtronic, Merck, Novartis, Philips and ReCor Medical. BS is a shareholder of InnoRa GmbH (Berlin, Germany) and has received lecture fees from B.Braun and Medtronic.